Treatable Traits in Interstitial Lung Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatable Traits in Interstitial Lung Disease — Stella

Home/Interstitial Lung Diseases (ILD)/

View on ClinicalTrials.gov

Recruiting

Back to Interstitial Lung Diseases (ILD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Australia

Sir Charles Gairdner Hospital, Perth, Western Australia

Fiona Stanley Hospital, Perth, Western Australia

Key details

Sponsor

The University of Western Australia

Collaborators

Fiona Stanley Hospital, Sir Charles Gairdner Hospital

Enrollment target

~110 participants

Started

September 2025

Primary completion

December 2026

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.